<DOC>
	<DOCNO>NCT02828683</DOCNO>
	<brief_summary>The aim study demonstrate safety efficacy TCD-10023 ( Ultimaster ) sirolimus elute stent patient acute ST-elevation myocardial infarction ( STEMI ) , prove superiority respect in-stent late loss 6 month Kaname bare metal stent non-inferiority respect Target Vessel Failure ( TVF ) 12 month .</brief_summary>
	<brief_title>Safety Efficacy TCD-10023 ( Ultimaster ) Drug-eluting Stent STEMI Patients - MASTER Study</brief_title>
	<detailed_description>MASTER prospective , randomize ( 3:1 ) , single blind , control , superiority ( efficacy ) non-inferiority ( safety efficacy ) , multi center , two-arm trial TCD-10023 ( Ultimaster ) drug elute stent ( test ) Kaname bare metal stent ( comparator ) . Patients follow 30 day , 6 , 12 month post-procedure annually 3 year . 500 patient clinical follow randomize 3:1 ratio ( 375 TCD-10023 arm 125 Kaname arm ) . Among , 100 patient randomize , 3:1 ratio , angiographic follow 6 month preselected hospital ( 75 TCD-10023 25 Kaname arm )</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Age equal 18 year Chest pain &gt; 20 minute Primary PCI &lt; 24h symptom onset STsegment elevation &gt; 1 mm &gt; 2 contiguous lead , ( presumably new ) leave bundle branch block , true posterior MI ST depression &gt; 1 mm &gt; 2 contiguous anterior lead Presence least one acute infarct artery target vessel one coronary artery stenosis native coronary artery 2.54.0 mm diameter cover one multiple stent Signed informed consent Female childbearing potential ( age &lt; 50 last menstruation within last 12 month ) , underwent tubal ligation , ovariectomy hysterectomy Known intolerance aspirin , clopidogrel , heparin , bivalirudin , cobalt , chromium , nickel , sirolimus contrast material Currently participate another trial reach primary endpoint Mechanical complication acute myocardial infarction ( e.g . cardiogenic shockâ€¦ ) Acute myocardial infarction secondary stent thrombosis Previously stented infarction relate artery ( IRA ) Planned surgery within 6 month PCI unless dual antiplatelet therapy maintain throughout perisurgical period Patients noncardiac comorbid condition life expectancy &lt; 1 year may result protocol noncompliance History bleeding diathesis know coagulopathy Use oral anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>DES</keyword>
	<keyword>PCI</keyword>
	<keyword>STEMI</keyword>
	<keyword>Interventional Cardiology</keyword>
</DOC>